Healthcare ECONOMIST

OCTOBER 16, 2024

Award for Excellence in Health Economics and Outcomes Research Application : Inmaculada Hernandez, PhD ; Professor, University of California San Diego; San Diego, CA, USA for the article, ”Changes In net prices and spending for pharmaceuticals after the introduction of new therapeutic competition.” [ Health Aff (Millwood).

Pharmaceuticals 56

Pharmaceuticals Health Technology 56

Bill Of Health

OCTOBER 15, 2021

The Pandemic Treaty (or other legal instrument) scheduled for discussion at the World Health Assembly in the fall of 2021 should focus on establishing the norm that the IP and knowledge needed to develop and produce essential pandemic health technologies become global public goods. and German governments in particular.

Pharmaceuticals 130

Pharmaceuticals Quality Assurance Health Technology Regulations 130

Healthcare ECONOMIST

MAY 30, 2023

Some policymakers have called for weakening of intellectual property protections for vaccines and other pharmaceutical products, with the aim to reduce the price and improve access to existing medical technologies, particularly in Eastern Europe and developing countries.

Life Sciences 78

Life Sciences Pharmaceuticals Medical Technology Health Technology 78

HIT Consultant

JULY 8, 2024

Moreover, when combined with digital health technologies, patient-led data enables continuous tracking of health metrics and symptoms, facilitating early detection of disease progression. Imagine a scenario where healthcare providers inform patients about the potential savings on treatments and medications right on the spot.

Healthcare 104

Healthcare Pharmaceuticals Healthcare Providers Patient Experience 104

Bill Of Health

SEPTEMBER 20, 2022

Dose shortages elevated the role of pharmaceutical executives. The answer to one of the most important public health questions of our time — who gets access to vaccines? The answer to one of the most important public health questions of our time — who gets access to vaccines? — Private decisions did not match public health need.

Pharmaceuticals 98

Pharmaceuticals Medical Technology Regulations Health Technology 98

HIT Consultant

JULY 25, 2024

Their award-winning medical AI software supports top pharmaceuticals, academic medical centers, and health technology companies globally. The company is renowned for developing Spark NLP, Healthcare NLP, the Healthcare GPT LLM, the Generative AI Lab No-Code Platform, and the Medical Chatbot.

Life Sciences 64

Life Sciences Pharmaceuticals Health Technology Healthcare Providers 64

Healthcare ECONOMIST

FEBRUARY 20, 2023

Disagreement is more likely to occur if a treatment intervention is musculoskeletal and less likely to occur if it is surgical or involves secondary prevention, or if the study was funded by a pharmaceutical company. Increasing the threshold to $200,000 raised the proportion of agreement (from 81 percent to 89 percent).

Pharmaceuticals 69

Pharmaceuticals Prevention Health Technology 69

HIT Consultant

DECEMBER 8, 2022

What You Should Know: – Sonde Health , a Boston, MA-based health technology company committed to bringing accessible health monitoring to everyone raises $19.25 Sonde licenses its platform to customers globally in two ways: Health Checks.

Pharmaceuticals 93

Pharmaceuticals Health Technology Healthcare 93

Healthcare ECONOMIST

JANUARY 17, 2024

“In health economics, these machine learning (ML) algorithms can be employed to look at data in various ways that can help researchers and payers better understand the safety and effectiveness of treatment. . Key topics have been data quality, fit-for-purpose use, registries, and external control arms” Drug Pricing.

Pharmaceuticals 80

Pharmaceuticals Health Technology Accountability Patient Experience 80

HIT Consultant

NOVEMBER 18, 2021

This marks Alira Health’s second digital health acquisition, furthering the company’s rapid expansion into patient-centric, technology-enabled solutions for healthcare providers, payers, and suppliers.

Life Sciences 97

Life Sciences Pharmaceuticals Patient Experience Health Technology 97

HIT Consultant

APRIL 4, 2024

What You Should Know: myTomorrows , a global health technology company connecting patients with all possible treatment options, today announced a new partnership with brainstrust, a UK-based charity that helps people living with a brain tumor reach their potential and thrive.

Pharmaceuticals 40

Pharmaceuticals Health Technology Healthcare Providers Life Sciences 40

Health Populi

DECEMBER 27, 2021

That a pharmaceutical company executive is speaking on the main stage at CES speaks to digital health’s mainstreaming beyond elite athletes and smartwatches that track activity.

Pharmaceuticals 162

Pharmaceuticals Prevention Doctors Health Technology 162

Health Populi

OCTOBER 6, 2021

That a pharmaceutical company executive is speaking on the main stage at CES speaks to the category’s mainstreaming beyond elite athletes and smartwatches that track activity. As Ford is quoted in the CES 2022 press release, “CES is the ideal stage to spotlight how technology is allowing people to take control of their health.

Pharmaceuticals 147

Pharmaceuticals Doctors Health Technology Medical Technology 147

Bill Of Health

MARCH 25, 2022

Association Between Payments by Pharmaceutical Manufacturers and Prescribing Behavior in Rheumatology. New EU regulation on health technology assessment of cancer medicines. J Gen Intern Med. 2022 Feb 9. Epub ahead of print. PMID: 35138547. Mayo Clin Proc. 2022 Feb;97(2):250-260. PMID: 35120693. 2022 Feb 21. Epub ahead of print.

Regulations 83

Regulations Pharmaceuticals Medicaid Health Technology 83

Healthcare ECONOMIST

NOVEMBER 14, 2022

By supporting decision-making on the development, authorisation and surveillance of medicines, a wide range of stakeholders will benefit, from patients and healthcare professionals to health technology assessment bodies and the pharmaceutical industry. Arlett et al.

Regulations 63

Regulations Pharmaceuticals Health Technology Health Data 63

Healthcare ECONOMIST

MARCH 20, 2022

The paper begins by comparing the ISPOR value flower against the recommendations from the Second Panel on Cost Effectiveness in Health and Medicine. The ISPOR Value Flower focused almost exclusively on pharmaceuticals whereas the Second Panel considered interventions more generally. Intervention types.

Pharmaceuticals 62

Pharmaceuticals Public Health services Health Technology 62

Healthcare ECONOMIST

MARCH 15, 2022

For instance, “in France, the request to conduct a post-registration study (PRS) can be issued for any technology for which relevant evidence gaps have been identified during the initial request by the manufacturer for registration in the list of reimbursable products and procedures (LPPR).

Pharmaceuticals 89

Pharmaceuticals Hospitals Health Technology 89

HIT Consultant

AUGUST 7, 2023

Sondra Pepe, SVP of Product Management, at AiCure The imperative to enhance access to quality care and research is a central concern gripping both the healthcare and pharmaceutical sectors.

Pharmaceuticals 98

Pharmaceuticals Healthcare Providers Healthcare Doctors 98

HIT Consultant

JUNE 26, 2022

Thanks to COVID-19 and numerous other factors, the adoption of digital health technologies used by patients in the home has skyrocketed. Accenture reported in 2021, for example, that remote patient monitoring technology adoption tripled among patients. Aniket Singh Rajput, Founder and CEO of Neuroglee.

Patient Experience 98

Patient Experience Rehabilitation Pharmaceuticals Health Technology 98

Health Populi

JULY 27, 2020

The report found three big shifts in global health citizens’ views on their personal health and health care delivery in the wake of the pandemic: Across all age groups, COVID-19 exacerbated peoples’ concerns about their physical and mental health in a very short time.

Pharmaceuticals 77

Pharmaceuticals Doctors Patient Experience Health Technology 77

HIT Consultant

JUNE 7, 2023

Despite years of investment in health technology and infrastructure, healthcare systems still rely heavily on patchy legacy systems that are not always up to the task of supporting evidence-based decision-making and advanced analytics.

Life Sciences 52

Life Sciences Healthcare Doctors Pharmaceuticals 52

Health Populi

NOVEMBER 15, 2018

patient organizations, online patient forums, and pharmaceutical companies? consumers believe that health-related information on the internet is as reliable as information from medical professionals. adults’ use of online search for health information, along with perspectives on the U.S. But social media influencers.

Doctors 81

Doctors Nursing Pharmaceuticals Health Technology 81

GoMoHealth

JUNE 22, 2021

Digital therapeutics are treatments that utilize digital health technologies to encourage changes in patient behavior to improve outcomes. What Are Digital Therapeutics? Even more uniquely impactful is that digital therapeutics tap into human motivation and cognition to deliver content and resources.

Healthcare 52

Healthcare Telemedicine Remote Care Pharmaceuticals 52

Health Advances

MAY 4, 2022

A large and aging population advanced IT infrastructure, and a single national healthcare system are among the features that will make Japan and South Korea ideal candidates to adopt digital health technologies at scale. These attractive features were offset by regulatory and reimbursement restrictions in the past.

Telemedicine 52

Telemedicine Regulations Pharmaceuticals Medical Services 52

HIT Consultant

MAY 27, 2022

Titus joined epocrates from Real Chemistry, a global health innovation company, where he served as EVP, sales & customer experience and led commercial teams for the Health Technology Products & Solutions and Commercial Consulting offerings, including PaaS, SaaS, and IaaS solutions for pharmaceutical and life science companies.

Life Sciences 52

Life Sciences Telemedicine Pharmaceuticals Health Technology 52

Health Populi

AUGUST 27, 2018

Rock Health’s 2018 survey reinforces what we know-we know about consumers’ willingness to share health data — and that is that the physician, above all health care entities, is the patient’s most trusted data steward. Check out Estonia and Switzerland for case studies on that. In the meantime, in the U.S.,

Telemedicine 51

Telemedicine Pharmaceuticals Health Data Doctors 51

Health Populi

AUGUST 22, 2022

In particular, the volume of health data from wearables, implantables, and other decentralized technologies is growing by 48% annually, according to a recent report from the Swiss Re Institute.

Life Sciences 117

Life Sciences Secondary Care Prevention Primary Care 117

Healthcare ECONOMIST

JULY 5, 2022

pain intensity, shortness of breath), functioning, events, or other aspects of health from the patient’s perspective. Often PROs are collected through questionnaires, but increasingly are being collected using digital health technologies (DHTs). Reports come from someone other than the patient or a health professional (e.g.,

Patient Experience 88

Patient Experience Health Technology Hospitals Regulations 88

Bill Of Health

JULY 28, 2023

Health Technology Assessment for Cancer Medicines across the G7 Countries and Oceania: An International, Cross-Sectional Study. The Rise and Fall of the Insulin Pricing Bubble. JAMA Netw Open. 2023 Jun 1;6(6):e2318074. Jenei K, Raymakers AJN, Bayle A, Berger-Thürmel K, Cherla A, Honda K, et al. Lancet Oncol. 2023 Jun;24(6):624-635.

Regulations 52

Regulations Medicaid Health Technology Pharmaceuticals 52

Bill Of Health

APRIL 7, 2023

Sharing of technology, trade secrets and know-how of potentially life-saving, versatile and important public health technologies is therefore left up to the markets. The second article complements the first one as it provides editorial commentary on the commercial realities that resulted from the U.S.

Health Technology 59

Health Technology Prevention Pharmaceuticals 59

Bill Of Health

OCTOBER 20, 2021

A full posting of abstracts/summaries of these articles may be found on our? Barenie R, Darrow J, Avorn J, Kesselheim A. Discovery and Development of Pregabalin (Lyrica): The Role of Public Funding.

Regulations 72

Regulations Health Technology Pharmaceuticals 72

Bill Of Health

OCTOBER 7, 2022

Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments. Health Aff (Millwood). Trapani D, Tay-Teo K, Tesch ME, Roitberg F, Sengar M, Altuna SC, Hassett MJ, Genazzani AA, Kesselheim AS, Curigliano G. Curr Oncol. 2022 Aug 16;29(8):5774-5791. 2022 Aug;41(8):1117-1124.

Health Science 52

Health Science Medicare Regulations Health Technology 52

Health Populi

DECEMBER 22, 2022

As the Trusted Future study learned, “ consumers need to be able to trust that their technologies will be effective at protecting their most sensitive health data.”. The post When Household Economics Blur with Health, Technology and Trust – Health Populi’s 2023 TrendCast appeared first on HealthPopuli.com.

Health Technology 62

Health Technology Primary Care Patient Experience Healthcare 62

Bill Of Health

NOVEMBER 16, 2023

These realities are consequences of an inequitable global health and economic system that is rooted in a history of colonialism and extractivism.

Prevention 111

Prevention Accountability Health Technology Regulations 111

HIT Consultant

MARCH 15, 2022

OptimizeRx , a provider of point-of-care technology solutions helping patients start and stay on therapy announced a definitive agreement to acquire the EvinceMed platform and related assets. EvinceMed is a provider in delivering end-to-end automation for specialty pharmaceutical transactions. million.

Life Sciences 98

Life Sciences Health Data Healthcare Hospitals 98

Healthcare ECONOMIST

JULY 11, 2022

Last month, the Office of Health Economics published a report titled “ Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose? ” I summarize some of the key challenges and solutions below. Challenge #1: Initial assessment of clinical effectiveness.

Life Sciences 94

Life Sciences Health Technology Pharmaceuticals 94

Healthcare ECONOMIST

JANUARY 25, 2022

That the book should be able to so clearly elucidate these issues should not come as a surprise as the authors–Peter Neumann, Joshua Cohen and Daniel Ollendorf–are pre-eminent experts in value-based pricing methodologies for pharmaceuticals. Are high drug prices a good thing? PBMs: The problem or the solution. The spread of HTA.

Pharmaceuticals 96

Pharmaceuticals Health Technology Medicaid Healthcare 96